BCX9250 is a potent small-molecule inhibitor of Activin A Receptor Type 1 (ACVR1/ALK2) for fibrodysplasia ossificans progressiva.

Wang H, Toutounchi S, Pignolo RJ, Cheng X, Parker CD, Liu Q, Muppa S, Kellogg-Yelder D, Polach KJ, Kotian PL, Babu YS, Chen X.

Open source

DOI: 10.1093/jbmrpl/ziag145
Published: 2026-08-28
Container: JBMR Plus
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/jbmrpl/ziag145,
  title = {BCX9250 is a potent small-molecule inhibitor of Activin A Receptor Type 1 (ACVR1/ALK2) for fibrodysplasia ossificans progressiva.},
  author = {Wang H and  Toutounchi S and  Pignolo RJ and  Cheng X and  Parker CD and  Liu Q and  Muppa S and  Kellogg-Yelder D and  Polach KJ and  Kotian PL and  Babu YS and  Chen X.},
  year = {2026},
  journal = {JBMR Plus},
  doi = {10.1093/jbmrpl/ziag145},
  url = {https://doi.org/10.1093/jbmrpl/ziag145}
}

RIS

TY  - JOUR
TI  - BCX9250 is a potent small-molecule inhibitor of Activin A Receptor Type 1 (ACVR1/ALK2) for fibrodysplasia ossificans progressiva.
AU  - Wang H
AU  -  Toutounchi S
AU  -  Pignolo RJ
AU  -  Cheng X
AU  -  Parker CD
AU  -  Liu Q
AU  -  Muppa S
AU  -  Kellogg-Yelder D
AU  -  Polach KJ
AU  -  Kotian PL
AU  -  Babu YS
AU  -  Chen X.
PY  - 2026
JO  - JBMR Plus
DO  - 10.1093/jbmrpl/ziag145
UR  - https://doi.org/10.1093/jbmrpl/ziag145
ER  -

APA

H, W., S, T., RJ, P., X, C., CD, P., Q, L., S, M., D, K., KJ, P., PL, K., YS, B., & X., C. (2026). BCX9250 is a potent small-molecule inhibitor of Activin A Receptor Type 1 (ACVR1/ALK2) for fibrodysplasia ossificans progressiva.. JBMR Plus. https://doi.org/10.1093/jbmrpl/ziag145

Source records

europe-pmc · retrieved 2026-11-10T12:17:49.460Z